Analysis of Profitability Ratios
Quarterly Data
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Humana Inc., profitability ratios (quarterly data)
Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Humana Inc. operating profit margin ratio deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Humana Inc. net profit margin ratio deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Humana Inc. ROE deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Humana Inc. ROA deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
Operating Profit Margin
Humana Inc., operating profit margin calculation (quarterly data)
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Income from operations | 1,236) | (348) | 1,206) | 1,436) | 1,719) | 124) | 1,172) | 1,215) | 1,289) | 61) | 628) | 1,236) | 1,223) | (346) | 1,823) | 2,435) | 1,074) | 362) | 868) | 1,115) | 847) | |||||||
| External revenues | 29,323) | 26,168) | 26,115) | 26,473) | 26,549) | 22,279) | 22,627) | 23,615) | 23,967) | 21,088) | 20,730) | 20,469) | 20,590) | 18,848) | 19,361) | 19,006) | 18,786) | 16,145) | 16,105) | 16,131) | 16,006) | |||||||
| Profitability Ratio | ||||||||||||||||||||||||||||
| Operating profit margin1 | 3.27% | 3.81% | 4.42% | 4.55% | 4.45% | 4.11% | 4.09% | 3.57% | 3.73% | 3.80% | 3.40% | 4.97% | 6.60% | 6.56% | 7.77% | 6.77% | 5.09% | 4.96% | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | — | 16.15% | 15.02% | 15.23% | 16.77% | 19.16% | 20.95% | 22.42% | 20.73% | 19.56% | 20.04% | 18.46% | 17.97% | 15.48% | 13.39% | 12.78% | 14.18% | 14.21% | — | — | — | |||||||
| Cigna Group | — | 4.40% | 4.34% | 4.38% | 4.54% | 4.69% | 4.59% | 4.71% | 4.64% | 4.60% | 4.59% | 4.57% | 4.98% | 5.12% | 5.37% | 5.47% | 5.18% | 5.31% | — | — | — | |||||||
| CVS Health Corp. | — | 3.85% | 4.04% | 1.88% | 2.33% | 2.41% | 2.02% | 4.35% | 4.39% | 4.54% | 4.75% | 4.93% | 5.19% | 5.19% | 5.44% | 5.36% | 4.89% | 4.69% | — | — | — | |||||||
| Elevance Health Inc. | 4.64% | 4.47% | 4.58% | 4.96% | 4.99% | 4.94% | 5.01% | 5.07% | 5.10% | 5.15% | 4.91% | 3.68% | 4.83% | 4.97% | 5.59% | 6.99% | 5.47% | 5.49% | — | — | — | |||||||
| Intuitive Surgical Inc. | 25.26% | 24.80% | 24.66% | 24.34% | 24.21% | 25.35% | 27.05% | 28.48% | 30.69% | 31.89% | 32.55% | 31.27% | 26.01% | 24.09% | 23.95% | 25.86% | 30.52% | 30.69% | — | — | — | |||||||
| Medtronic PLC | 17.83% | 17.56% | 18.17% | 19.02% | 19.37% | 18.15% | 17.89% | 16.68% | 14.78% | 14.89% | 11.44% | 12.77% | 14.25% | 16.57% | 20.67% | 20.47% | 21.25% | 20.51% | 20.48% | 20.22% | 21.70% | |||||||
| Shockwave Medical Inc. | — | 21.79% | 23.57% | 24.55% | 26.67% | 25.35% | 22.26% | 16.98% | 10.70% | -0.37% | -17.49% | -35.61% | -75.95% | -96.86% | -109.72% | -127.95% | -115.35% | -120.76% | — | — | — | |||||||
| UnitedHealth Group Inc. | — | 8.80% | 8.86% | 8.83% | 8.87% | 8.83% | 8.65% | 8.32% | 8.19% | 8.40% | 7.91% | 7.73% | 9.24% | 8.76% | 9.55% | 9.89% | 8.12% | 8.19% | — | — | — | |||||||
Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q1 2024 Calculation
Operating profit margin = 100
× (Income from operationsQ1 2024
+ Income from operationsQ4 2023
+ Income from operationsQ3 2023
+ Income from operationsQ2 2023)
÷ (External revenuesQ1 2024
+ External revenuesQ4 2023
+ External revenuesQ3 2023
+ External revenuesQ2 2023)
= 100 × (1,236 + -348 + 1,206 + 1,436)
÷ (29,323 + 26,168 + 26,115 + 26,473)
= 3.27%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Humana Inc. operating profit margin ratio deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
Net Profit Margin
Humana Inc., net profit margin calculation (quarterly data)
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net income attributable to Humana | 741) | (541) | 832) | 959) | 1,239) | (15) | 1,195) | 696) | 930) | (14) | 1,531) | 588) | 828) | (274) | 1,340) | 1,828) | 473) | 512) | 689) | 940) | 566) | |||||||
| External revenues | 29,323) | 26,168) | 26,115) | 26,473) | 26,549) | 22,279) | 22,627) | 23,615) | 23,967) | 21,088) | 20,730) | 20,469) | 20,590) | 18,848) | 19,361) | 19,006) | 18,786) | 16,145) | 16,105) | 16,131) | 16,006) | |||||||
| Profitability Ratio | ||||||||||||||||||||||||||||
| Net profit margin1 | 1.84% | 2.36% | 2.97% | 3.45% | 3.28% | 3.03% | 3.07% | 3.52% | 3.52% | 3.54% | 3.31% | 3.13% | 4.78% | 4.43% | 5.67% | 5.00% | 3.89% | 4.20% | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | — | 14.27% | 12.92% | 12.83% | 13.98% | 15.88% | 17.52% | 18.78% | 17.35% | 16.42% | 17.12% | 15.85% | 15.33% | 12.99% | 10.50% | 9.89% | 11.15% | 11.56% | — | — | — | |||||||
| Cigna Group | — | 2.66% | 2.81% | 3.59% | 3.71% | 3.72% | 3.69% | 3.08% | 3.07% | 3.11% | 4.97% | 4.93% | 5.22% | 5.31% | 3.40% | 3.43% | 3.22% | 3.35% | — | — | — | |||||||
| CVS Health Corp. | — | 2.34% | 2.48% | 0.86% | 1.20% | 1.29% | 1.00% | 2.66% | 2.68% | 2.72% | 2.67% | 2.60% | 2.74% | 2.68% | 3.00% | 3.14% | 2.77% | 2.59% | — | — | — | |||||||
| Elevance Health Inc. | 3.66% | 3.52% | 3.63% | 3.89% | 3.89% | 3.87% | 4.09% | 4.13% | 4.37% | 4.46% | 4.17% | 3.32% | 3.82% | 3.78% | 4.26% | 5.27% | 4.42% | 4.66% | — | — | — | |||||||
| Intuitive Surgical Inc. | 27.16% | 25.24% | 22.14% | 21.38% | 20.40% | 21.25% | 22.52% | 24.05% | 27.84% | 29.85% | 30.78% | 31.43% | 25.78% | 24.33% | 24.45% | 26.07% | 30.11% | 30.80% | — | — | — | |||||||
| Medtronic PLC | 11.47% | 12.03% | 13.20% | 14.03% | 16.75% | 15.90% | 15.46% | 14.79% | 12.29% | 11.97% | 10.36% | 12.69% | 15.80% | 16.56% | 17.11% | 15.11% | 14.41% | 15.16% | 16.10% | 7.44% | 10.56% | |||||||
| Shockwave Medical Inc. | — | 20.17% | 36.33% | 39.56% | 43.18% | 44.10% | 20.48% | 15.11% | 9.70% | -3.85% | -21.60% | -40.60% | -83.47% | -96.92% | -108.73% | -126.34% | -112.25% | -119.06% | — | — | — | |||||||
| UnitedHealth Group Inc. | — | 6.09% | 6.09% | 6.11% | 6.21% | 6.25% | 6.21% | 5.99% | 5.91% | 6.06% | 5.56% | 5.37% | 6.46% | 6.03% | 6.66% | 6.94% | 5.63% | 5.76% | — | — | — | |||||||
Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q1 2024 Calculation
Net profit margin = 100
× (Net income attributable to HumanaQ1 2024
+ Net income attributable to HumanaQ4 2023
+ Net income attributable to HumanaQ3 2023
+ Net income attributable to HumanaQ2 2023)
÷ (External revenuesQ1 2024
+ External revenuesQ4 2023
+ External revenuesQ3 2023
+ External revenuesQ2 2023)
= 100 × (741 + -541 + 832 + 959)
÷ (29,323 + 26,168 + 26,115 + 26,473)
= 1.84%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Humana Inc. net profit margin ratio deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
Return on Equity (ROE)
Humana Inc., ROE calculation (quarterly data)
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net income attributable to Humana | 741) | (541) | 832) | 959) | 1,239) | (15) | 1,195) | 696) | 930) | (14) | 1,531) | 588) | 828) | (274) | 1,340) | 1,828) | 473) | 512) | 689) | 940) | 566) | |||||||
| Stockholders’ equity | 16,130) | 16,262) | 16,949) | 16,834) | 16,577) | 15,311) | 16,254) | 15,490) | 15,319) | 16,080) | 16,260) | 14,843) | 14,190) | 13,728) | 15,768) | 14,416) | 12,355) | 12,037) | 11,601) | 11,872) | 10,841) | |||||||
| Profitability Ratio | ||||||||||||||||||||||||||||
| ROE1 | 12.34% | 15.31% | 17.79% | 20.07% | 18.79% | 18.33% | 17.27% | 20.29% | 19.81% | 18.24% | 16.44% | 16.72% | 26.23% | 24.53% | 26.34% | 24.29% | 21.16% | 22.49% | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| ROE, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | — | 14.83% | 13.77% | 13.88% | 15.68% | 18.90% | 22.11% | 23.44% | 21.82% | 19.75% | 21.04% | 18.86% | 17.06% | 13.71% | 10.78% | 10.17% | 11.84% | 11.86% | — | — | — | |||||||
| Cigna Group | — | 11.17% | 11.61% | 14.64% | 15.17% | 14.86% | 14.69% | 11.94% | 11.69% | 11.39% | 17.68% | 16.73% | 17.52% | 16.81% | 11.03% | 11.11% | 10.91% | 11.26% | — | — | — | |||||||
| CVS Health Corp. | — | 10.91% | 11.57% | 4.02% | 5.57% | 5.84% | 4.46% | 10.86% | 10.83% | 10.54% | 10.20% | 9.83% | 10.44% | 10.35% | 11.56% | 12.14% | 11.08% | 10.39% | — | — | — | |||||||
| Elevance Health Inc. | 15.38% | 15.23% | 15.82% | 16.78% | 16.62% | 16.59% | 17.26% | 17.04% | 17.36% | 16.93% | 15.44% | 12.10% | 13.92% | 13.77% | 14.61% | 17.17% | 15.08% | 15.15% | — | — | — | |||||||
| Intuitive Surgical Inc. | 14.24% | 13.51% | 12.10% | 12.00% | 11.70% | 11.98% | 11.97% | 11.93% | 13.58% | 14.32% | 14.80% | 14.97% | 11.56% | 10.90% | 11.38% | 13.00% | 16.30% | 16.69% | — | — | — | |||||||
| Medtronic PLC | 7.07% | 7.30% | 7.90% | 8.33% | 9.88% | 9.59% | 9.35% | 9.05% | 7.54% | 7.01% | 5.70% | 7.05% | 8.77% | 9.44% | 10.26% | 9.23% | 8.78% | 9.25% | 9.87% | 4.56% | 6.30% | |||||||
| Shockwave Medical Inc. | — | 22.03% | 40.56% | 39.54% | 42.16% | 42.24% | 24.73% | 18.02% | 10.82% | -3.78% | -17.23% | -25.36% | -34.53% | -29.11% | -27.24% | -26.32% | -32.11% | -26.53% | — | — | — | |||||||
| UnitedHealth Group Inc. | — | 25.22% | 25.67% | 25.63% | 25.46% | 25.87% | 26.03% | 25.07% | 23.98% | 24.09% | 21.95% | 21.03% | 25.42% | 23.52% | 25.65% | 26.87% | 24.14% | 24.02% | — | — | — | |||||||
Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q1 2024 Calculation
ROE = 100
× (Net income attributable to HumanaQ1 2024
+ Net income attributable to HumanaQ4 2023
+ Net income attributable to HumanaQ3 2023
+ Net income attributable to HumanaQ2 2023)
÷ Stockholders’ equity
= 100 × (741 + -541 + 832 + 959)
÷ 16,130 = 12.34%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Humana Inc. ROE deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |
Return on Assets (ROA)
Humana Inc., ROA calculation (quarterly data)
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||
| Net income attributable to Humana | 741) | (541) | 832) | 959) | 1,239) | (15) | 1,195) | 696) | 930) | (14) | 1,531) | 588) | 828) | (274) | 1,340) | 1,828) | 473) | 512) | 689) | 940) | 566) | |||||||
| Total assets | 50,091) | 47,065) | 55,905) | 56,455) | 54,776) | 43,055) | 50,765) | 46,820) | 46,308) | 44,358) | 45,320) | 38,070) | 37,415) | 34,969) | 38,477) | 38,455) | 34,633) | 29,074) | 29,180) | 28,913) | 28,349) | |||||||
| Profitability Ratio | ||||||||||||||||||||||||||||
| ROA1 | 3.97% | 5.29% | 5.39% | 5.98% | 5.69% | 6.52% | 5.53% | 6.71% | 6.55% | 6.61% | 5.90% | 6.52% | 9.95% | 9.63% | 10.79% | 9.11% | 7.55% | 9.31% | — | — | — | |||||||
| Benchmarks | ||||||||||||||||||||||||||||
| ROA, Competitors2 | ||||||||||||||||||||||||||||
| Abbott Laboratories | — | 7.82% | 7.16% | 7.04% | 7.87% | 9.31% | 10.84% | 11.53% | 10.44% | 9.40% | 9.82% | 8.70% | 7.86% | 6.20% | 4.90% | 4.52% | 5.36% | 5.43% | — | — | — | |||||||
| Cigna Group | — | 3.38% | 3.54% | 4.43% | 4.56% | 4.63% | 4.59% | 3.59% | 3.53% | 3.46% | 5.44% | 5.29% | 5.55% | 5.44% | 3.31% | 3.30% | 3.18% | 3.28% | — | — | — | |||||||
| CVS Health Corp. | — | 3.34% | 3.42% | 1.17% | 1.66% | 1.82% | 1.36% | 3.55% | 3.43% | 3.39% | 3.23% | 3.12% | 3.22% | 3.11% | 3.41% | 3.51% | 3.13% | 2.98% | — | — | — | |||||||
| Elevance Health Inc. | 5.58% | 5.50% | 5.50% | 5.87% | 5.69% | 5.86% | 6.03% | 6.05% | 6.21% | 6.26% | 5.63% | 4.40% | 4.93% | 5.28% | 5.72% | 6.72% | 5.80% | 6.21% | — | — | — | |||||||
| Intuitive Surgical Inc. | 12.56% | 11.64% | 10.31% | 10.25% | 10.05% | 10.19% | 10.39% | 10.47% | 12.02% | 12.58% | 13.06% | 13.20% | 10.17% | 9.50% | 9.92% | 11.24% | 14.02% | 14.17% | — | — | — | |||||||
| Medtronic PLC | 3.99% | 4.13% | 4.32% | 4.63% | 5.79% | 5.54% | 5.35% | 5.13% | 4.23% | 3.87% | 2.97% | 3.69% | 4.70% | 5.28% | 5.73% | 5.13% | 4.84% | 5.16% | 5.54% | 2.56% | 3.53% | |||||||
| Shockwave Medical Inc. | — | 9.40% | 16.55% | 31.01% | 30.72% | 33.43% | 18.50% | 13.18% | 7.78% | -2.64% | -12.69% | -19.12% | -26.21% | -24.15% | -23.01% | -22.48% | -25.86% | -22.04% | — | — | — | |||||||
| UnitedHealth Group Inc. | — | 8.18% | 7.69% | 7.53% | 7.30% | 8.19% | 7.99% | 7.93% | 7.89% | 8.15% | 7.24% | 6.90% | 8.23% | 7.81% | 8.76% | 8.88% | 7.27% | 7.96% | — | — | — | |||||||
Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q1 2024 Calculation
ROA = 100
× (Net income attributable to HumanaQ1 2024
+ Net income attributable to HumanaQ4 2023
+ Net income attributable to HumanaQ3 2023
+ Net income attributable to HumanaQ2 2023)
÷ Total assets
= 100 × (741 + -541 + 832 + 959)
÷ 50,091 = 3.97%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Humana Inc. ROA deteriorated from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024. |